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A new role for the cellular PABP repressor
Paip2 as an innate restriction factor
capable of limiting productive
cytomegalovirus replication
Caleb McKinney,1 Dong Yu,2 and Ian Mohr1,3
1
Department of Microbiology, New York University Cancer Institute, New York University School of Medicine, New York, New
York 10016, USA; 2Department of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri
63110, USA

The capacity of polyadenylate-binding protein PABPC1 (PABP1) to stimulate translation is regulated by its
repressor, Paip2. Paradoxically, while PABP accumulation promotes human cytomegalovirus (HCMV) protein
synthesis, we show that this is accompanied by an analogous increase in the abundance of Paip2 and EDD1, an E3
ubiquitin ligase that destabilizes Paip2. Coordinate control of PABP1, Paip2, and EDD1 required the virus-encoded
UL38 mTORC1 activator and resulted in augmented Paip2 synthesis, stability, and association with PABP1. Paip2
synthesis also increased following serum stimulation of uninfected normal fibroblasts, suggesting that this
coregulation may play a role in how uninfected cells respond to stress. Significantly, Paip2 accumulation was
dependent on PABP accrual, as preventing PABP1 accumulation suppressed viral replication and inhibited the
corresponding Paip2 increase. Furthermore, depleting Paip2 restored the ability of infected cells to assemble the
translation initiation factor eIF4F, promoting viral protein synthesis and replication without increasing PABP1.
This establishes a new role for the cellular PABP1 inhibitor Paip2 as an innate defense that restricts viral protein
synthesis and replication. Moreover, it illustrates how a stress-induced rise in PABP1 triggered by virus infection
can counter and surpass a corresponding increase in Paip2 abundance and stability.
[Keywords: Paip2; innate defense; HCMV replication; translation control; PABP; mTORC1]
Supplemental material is available for this article.
Received May 6, 2013; revised version accepted July 19, 2013.

The control of gene expression at the level of mRNA
translation facilitates swift responses to an ever-changing
environment and plays a fundamental role in the response
to stress and viral infection (Mohr and Sonenberg 2012). To
replicate productively, viruses must seize control of the
cellular protein synthesis machinery and the complex
networks that regulate its activity. At the same time, host
defenses use translational control mechanisms to respond
to microbial infection and mobilize innate host defenses
(Walsh and Mohr 2011). While some of these responses can
affect specific mRNAs, others can globally impact the
translational capacity of the cell (Mohr and Sonenberg
2012; Walsh et al. 2013). As such, the steady-state level of
translation initiation factors and repressors are poised to
play a powerful role in controlling translation in infected
and uninfected cells.

3
Corresponding author
E-mail ian.mohr@med.nyu.edu
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.221341.113.

Unlike many viruses that impair host mRNA translation
or inactivate cellular translation factors, host mRNA
translation proceeds in human cytomegalovirus (HCMV)infected cells (Stinski 1977). To ensure that viral mRNAs
(which contain 7-methyl guanosine [m7G]-capped 59 and
39 polyadenylated termini) effectively compete for limiting
translation factors, HCMV infection triggers an increase
in the intracellular concentration of key initiation factors,
including the cellular polyadenylate-binding protein
PABPC1 (PABP1) and the multisubunit cap-binding complex eIF4F (Kudchodkar et al. 2004; Isler et al. 2005; Walsh
et al. 2005; Perez et al. 2011). Comprised of the cap-binding
protein eIF4E and the RNA helicase eIF4A bound to the
large molecular scaffold eIF4G, eIF4F complex assembly
is regulated on the m7GTP cap structure, facilitating 40S
ribosome subunit loading onto the mRNA 59 end (Jackson
et al. 2010). PABP1 bound to the mRNA 39 poly(A) tail
stimulates translation by binding to eIF4G and in effect
juxtaposes the mRNA 39 end with the eIF4F complex
assembled on the 59 end, forming a closed loop or circular
topology (Kahvejian et al. 2001). While the level of mRNAs
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encoding the individual eIF4F subunits increases upon
infection, PABP1 abundance is controlled at the level of
translation and is dependent on the virus-encoded mTORC1
activator encoded by the UL38 gene. Importantly, preventing the HCMV-induced rise in PABP1 levels interferes with
eIF4F assembly, viral protein production, and viral replication (McKinney et al. 2012). Thus, successfully increasing
the concentration of the host PABP1 represents an important aspect of the productive viral life cycle.
Multiple distinct regulatory pathways maintain PABP1
homeostasis in cells. An adenine-rich autoregulatory region in the PABP1 mRNA 59 untranslated region (UTR)
reportedly represses its synthesis (Wu and Bag 1998; Patel
et al. 2005). As a member of an mRNA family that contains
a 59-terminal oligopyrimidine (TOP) region in the 59 UTR,
PABP1 synthesis is coordinately regulated at the level of
translation, together with other host ribosomal protein
genes and translation factors, and is stimulated in response
to mitogenic, growth, and nutritional stimuli (Hornstein
et al. 1999a). TOP mRNA translation is also stimulated
by HCMV infection (McKinney et al. 2012). PABP1 activity, however, is controlled through its association with
interacting protein partners (Derry et al. 2006). Besides
associating with eIF4G, PABP1 interacts with Paip1 (an
eIF4G-like molecule that stimulates translation) and Paip2
(a potent translation repressor) (Craig et al. 1998; Khaleghpour
et al. 2001a; Roy et al. 2002; Martineau et al. 2008).
Paip2 inhibits translation by displacing PABP1 from the
poly(A) tail at the mRNA 39 end and preventing PABP1
from binding eIF4G (Khaleghpour et al. 2001b; Karim
et al. 2006). To ensure proper control of gene expression,
PABP1 and its repressor, Paip2, are tightly coregulated, as
PABP1 depletion by RNAi triggers a corresponding reduction in Paip2. This requires binding of Paip2 to the E3
ubiquitin ligase EDD1, as opposed to PABP1, and illustrates how differential binding to EDD1 and PABP1
control Paip2 levels (Yoshida et al. 2006). A role for the
converse scenario—namely, how Paip2 might respond to
elevated PABP1 levels—has not been investigated and
remains unknown, in part due to the difficulty in overexpressing PABP (Wormington et al. 1996; Wu and Bag
1998; Hornstein et al. 1999b; Ma et al. 2006). Here we show
that EDD1 and newly synthesized Paip2 levels surprisingly
increased in response to PABP1 accumulation induced
upon infection with HCMV. This required expression of
the virus-encoded UL38 mTORC1 activator. Paip2 stability also increased in HCMV-infected cells, and Paip2 was
detected bound to PABP1 even though EDD1 levels were
elevated. Significantly, besides suppressing eIF4F assembly,
viral protein production, and replication, preventing the
HCMV-induced increase in PABP1 abundance inhibited
Paip2 accumulation. Moreover, depleting Paip2 restored
virus protein production and replication in cells where
the PABP increase was blocked by RNAi. Thus, Paip2
depletion obviates the need to increase PABP1 abundance
in HCMV-infected cells. Taken together, this demonstrates that while increasing PABP and Paip2 levels are
both dependent on mTORC1 signaling, Paip2 abundance
specifically increases in response to PABP accumulation.
This not only suggests that the coordinate increase in
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Paip2 synthesis and stability naturally limits PABP1 activity, but establishes that it can function as a previously
unrecognized innate host defense with the capacity to
restrict viral protein synthesis and replication. Sufficiently increasing cellular PABP1 levels allows HCMV
to overcome this host restriction and effectively counter
the potential negative impact of the Paip2 repressor. This
is the first example illustrating how a virus can manipulate the PABP1/Paip2 homeostatic switch by increasing
PABP1 levels to facilitate productive virus growth.
Results
PABP1 accumulation induced by HCMV infection
is accompanied by a corresponding increase in Paip2
and EDD1 abundance
To investigate how PABP1 function is influenced by its
endogenous cellular inhibitor, Paip2, in HCMV-infected
cells, we first compared the overall abundance of Paip2
mRNA and protein in mock-infected versus HCMV-infected
normal human diploid fibroblasts (NHDFs). Given that
Paip2 inhibits PABP1 (Fig. 1A) and that the virus-induced
increase in PABP1 levels stimulates HCMV replication, it
was surprising that Paip2 and EDD1 both accumulated
along with PABP1 between 30 and 48 h post-infection
(hpi) (Fig. 1B). By 72 hpi, overall levels of Paip2 and EDD1
rose between fourfold and fivefold, and PABP abundance
increased between sevenfold and eightfold (Supplemental
Fig. S1). The HCMV-induced increase in EDD1 protein
abundance was not accompanied by a detectable corresponding increase in steady-state mRNA levels, whereas
the increase in Paip2 protein was only accompanied by a
modest increase in mRNA (Fig. 1C), suggesting an underlying post-transcriptional control strategy similar to
what we previously defined for PABP1 (Perez et al. 2011).
Importantly, while reducing PABP1 abundance has been
shown to trigger a corresponding decrease in Paip2 and
EDD1 levels (Yoshida et al. 2006), this is the first demonstration that these factors are coordinately up-regulated.
Since PABP1 function is controlled by the relative abundance of Paip2 and PABP1, the mechanisms underlying
the coordinate regulation of PABP1, Paip2, and EDD1 in
HCMV-infected cells were investigated.
Paip2 is regulated by the HCMV-encoded UL38
mTORC1 activator
UL38 is a multifunctional HCMV-encoded early gene
product that may serve different roles in discrete compartments of the cell (Tenney and Colberg-Poley 1991; Varnum
et al. 2004; Qian et al. 2011). One characterized role for
UL38 in positively regulating translation is binding to
TSC2, inhibiting the tuberous sclerosis complex, constitutively activating mTORC1, and subsequently disabling
the 4E-BP1 translation initiation inhibitor (Moorman et al.
2008). We showed that UL38 not only regulates PABP1
accumulation in an mTORC1-dependent manner that
requires 4E-BP1 inactivation, but also translationally activates the TOP motif in the 59 UTR of the mRNA
(McKinney et al. 2012). While the TOP motif confers
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translational repression during nutrient and growth factor starvation and consists of a 59 terminal cytosine
residue followed by a 4- to 13-nucleotide (nt) sequence
of pyrimidine residues (Meyuhas 2000), the Paip2 mRNA
does not contain a canonical TOP motif in its 59 UTR (Fig.
2A). To determine whether Paip2 accumulation in
HCMV-infected cells was, like PABP1, dependent on
UL38, NHDFs were mock-infected or infected with wildtype HCMV, a UL38-deficient HCMV, or a virus in which
the UL38 mutation was repaired to wild type, and Paip2,
PABP1, and EDD1 abundance was evaluated by immunoblotting. Although Paip2, PABP1, and EDD1 all accumulated in cells infected with wild-type HCMV, their
accumulation was impaired in cells infected with a UL38deficient virus (Fig. 2B). Infection with a revertant virus

where the UL38 gene was reintroduced into the UL38deficient (DUL38) HCMV genome restored robust accumulation of PABP1, Paip2, and EDD1 to near wild-type levels,
proving that the coordinate accumulation of PABP, Paip2,
and EDD1 was indeed UL38-dependent (Fig. 2B).
UL38 is a multifunctional protein that not only activates
mTORC1, but also regulates apoptosis and the unfolded
protein response (Terhune et al. 2007; Qian et al. 2011). In
addition, the control of Paip2 abundance is incompletely
understood. To determine whether mTOR activity in
HCMV-infected cells regulates Paip2 steady-state levels,
mock-infected and HCMV-infected NHDFs were treated
with the mTORC1-selective inhibitor rapamycin or the
mTOR active site inhibitor PP242 (Feldman et al. 2009).
The virus-induced increase in PABP1 and Paip2 was subsequently evaluated by immunoblotting. Figure 3A demonstrates that Paip2 accumulation in HCMV-infected cells
was reduced by rapamycin treatment and nearly abrogated by PP242. Thus, Paip2 accumulation in response to
HCMV infection, similar to PABP accumulation, requires
mTOR signaling. The greater reduction in PABP1 and
Paip2 achieved with PP242 versus rapamycin could indicate that the levels of both proteins are controlled by
4E-BP1 phosphorylation, which is differentially sensitive
to PP242 compared with rapamycin (Feldman et al.
2009). Indeed, 4E-BP1 phosphorylation controls the virusinduced PABP1 increase (Perez et al. 2011). Alternatively,
as HCMV infection becomes resistant to rapamycin after
36 hpi, it is possible that mTORC2 could potentially be
involved (Kudchodkar et al. 2004, 2006).
To determine whether ectopic expression of UL38 is
sufficient to induce Paip2 accumulation in uninfected

Figure 1. Accumulation of the cellular PABP repressor Paip2;
its negative regulator, EDD1; and PABP1 in HCMV-infected
cells. (A) Cartoon illustrating control of PABP homeostasis in
response to serum stimulation or HCMV infection. PABP is
encoded by an mRNA containing a TOP element and is repressed in growth-arrested cells (Hornstein et al. 1999a). Serum
stimulation or HCMV infection activates mTORC1 and stimulates new PABP synthesis, which in turn promotes eIF4F assembly
and 40S ribosome recruitment to the mRNA 59 end (Perez et al.
2011; McKinney et al. 2012). The PABP repressor Paip2 regulates PABP1 function by (1) preventing its association with the
mRNA poly(A) tail and (2) binding to PABP1 and preventing its
association with eIF4G, both of which repress translation (Derry
et al. 2006). Excess Paip2 that is not bound to PABP interacts
with the E3 ubiquitin ligase EDD1, which targets Paip2 for
proteolysis (Yoshida et al. 2006). While PABP depletion stimulates Paip2 degradation, how Paip2 responds to PABP accumulation is unknown and is depicted as a question mark. (B)
Asynchronous NHDFs were mock-infected (0 hpi) or infected
with HCMV at a multiplicity of 3. At the indicated times postinfection, total protein was isolated, fractionated by SDS-PAGE,
and analyzed by immunoblotting with the indicated antisera.
(C) As in B except at the indicated times post-infection, total
RNA was isolated through Trizol extraction and subjected to
RT-qPCR using the indicated primer sets. Each reaction product
was normalized to the signal obtained using 18S rRNA, and the
fold induction upon infection was calculated as described (Perez
et al. 2011).
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UL38 were treated with serum or dox in the presence of
rapamyin or PP242. Figure 3B shows that either serum or
UL38 induced Paip2 accumulation in a rapamycin or

Figure 2. Paip2 and EDD1 mRNAs do not contain a canonical
TOP element but encode proteins that accumulate in a UL38dependent manner together with PABP1. (A) Comparison of the
Paip2 mRNA 59 terminus with those of canonical TOP-bearing
mRNAs, which contain a 59-terminal cytosine residue followed by
a 4- to 14-nt pyrimidine tract and a GC-rich region. (B) Asynchronous NHDFs were either mock-infected or infected (MOI = 3) with
wild-type (WT) HCMV, a UL38-deficient mutant virus (DUL38),
or a revertant virus where the UL38 deficiency was repaired by
reintroducing a wild-type UL38 gene (Rev). At 48 hpi, total
protein was isolated, fractionated by SDS-PAGE, and analyzed
by immunoblotting with the indicated antisera.

cells, primary NHDFs were transduced with a lentivirus
expressing UL38 under the control of a doxycycline (dox)inducible promoter. Following growth arrest by serum
deprivation, the cells were either exposed to serum in the
absence of dox or treated with dox in the absence of serum.
After metabolic labeling of newly synthesized proteins
with 35S amino acids for 1 h, total protein was harvested,
fractionated by SDS-PAGE, and visualized by autoradiography (Fig. 3B). In addition, Paip2 synthesis was evaluated by immunoprecipitation. Both serum exposure in
the absence of dox and dox treatment in the absence of
serum were sufficient to stimulate total cellular protein
synthesis and new Paip2 synthesis (Fig. 3B, cf. lanes 2–5).
Importantly, UL38 induction was more effective than
serum stimulation at stimulating 35S amino acid incorporation into total protein and newly synthesized Paip2.
Thus, ectopic UL38 expression in uninfected cells in the
absence of any other HCMV-encoded proteins is necessary and sufficient to increase Paip2 abundance.
To determine whether Paip2 synthesis in response to
UL38 expression in uninfected NHDFs requires mTOR
activity, serum-deprived NHDFs that express inducible
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Figure 3. Paip2 abundance in response to HCMV infection,
serum stimulation, or UL38 induction is regulated by mTORC1.
(A) Asynchronous NHDFs were either mock-infected or HCMVinfected in the presence of DMSO, the mTORC1-selective inhibitor rapamycin (100 nM), or the active site mTOR inhibitor
PP242 (2.5 mM). At 48 hpi, total protein was collected, fractionated by SDS-PAGE, and analyzed by immunoblotting with the
indicated antisera. (B, lanes 1–4) NHDFs that express UL38
upon induction with dox cells were growth-arrested by serum
deprivation; treated for 1 h with DMSO, rapamycin (100 nM), or
PP242 (2.5 mM); and subsequently untreated or serum-stimulated with 20% FBS for 20 min in the presence or absence of
drug. (Lanes 5–7) Alternatively, cells were dox-treated for 72 h.
Subsequently, cultures were metabolically pulse-labeled for 1 h
with [35S]Met-Cys, and total protein was collected. A sample of
the lysate was immunoprecipitated using anti-Paip2 antisera.
Lysates (input panel) and isolated immune complexes (Paip2
panel) were fractionated by SDS-PAGE, and radiolabeled polypeptides were directly visualized by exposing the fixed, dried gel
to X-ray film. The migration of molecular weight standards (in
kilodaltons) is shown to the left of the top panel.
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PP242-sensitive manner. Thus, new Paip2 synthesis and
accumulation in uninfected NHDFs is induced in response
to UL38 expression in a manner dependent on mTORC1
activity. Notably, unlike PABP mRNA, whose translation
is also stimulated by mTORC1, Paip2 mRNA does not
contain a canonical TOP element, raising the possibility
that Paip2 synthesis and accumulation are intrinsically
responsive to PABP abundance.
Paip2 stability increases during infection through
increased binding to PABP1
By associating with PABP1 in a 2:1 stoichiometry via two
conserved PABP-interacting motifs (PAM1 and PAM2),
Paip2 inhibits PABP1 (Karim et al. 2006). When PABP1 is
limiting, PAM2 binds to the PABC domain of PABP1 or
EDD1 (Yoshida et al. 2006). To understand how the virus

might benefit from increasing PABP1 while simultaneously stimulating accumulation of Paip2 and EDD1,
the possibility that the association of PABP1 with Paip2
during infection might be impaired was investigated.
Nonionic detergent lysates prepared from mock-infected
or HCMV-infected cultures were immunoprecipitated
using anti-Paip2 or anti-PABP1 sera, and the amount of
Paip2 and PABP1 present in immune complexes was
evaluated by immunoblotting. While the total levels of
both proteins increased in HCMV-infected cells (see Input
in Fig. 4A), it was surprising that (1) PABP1 and Paip2
remained associated, and (2) the overall amount of associated Paip2 and PABP increased (Fig. 4A). However, it
remained possible that the ratio of free PABP1 to free Paip2
could be altered during infection in a manner dependent
on their rates of synthesis and turnover. To determine the
impact of HCMV infection on the stability of PABP and
Paip2, primary NHDFs either mock-infected or infected
with HCMV were treated with cycloheximide (CHX) to
attenuate new protein synthesis, and total EDD1, Paip2,
and PABP1 levels were measured over a 9-h time period
by immunoblotting. The efficacy of CHX treatment was
verified by monitoring the inhibition of 35S amino acid
incorporation into acid-insoluble material (data not
shown). While PABP1 and EDD1 levels remained fairly
consistent throughout the CHX treatment in mockinfected cells, decreased Paip2 levels were readily detected
shortly after treatment (Fig. 4B). In contrast, Paip2 abundance decreased more slowly in HCMV-infected cells than
in mock-infected cells. Quantification of this decay
revealed that Paip2 half-life nearly doubled in HCMVinfected cells, as Paip2 levels decreased by 50% after 5 h
of CHX treatment in uninfected cells versus 9 h in infected
cells (Fig. 4B). Since Paip2 homeostasis is dependent on its

Figure 4. Paip2 associates with PABP and is stabilized in
HCMV-infected cells. (A) Soluble cell-free extracts were prepared from asynchronous NHDFs that were either mockinfected ( ) or HCMV-infected (+) at 48 hpi (MOI = 3). Samples
were immunoprecipitated (IP) using anti-Paip2 or anti-PABP1
antisera. Isolated immune complexes and a sample of the input
extract were fractionated by SDS-PAGE and analyzed by Western blotting (WB) using antisera specific for Paip2 or PABP1.
(B) NHDFs that were mock-infected or infected with HCMV
(MOI = 3) were treated with 100 mg/mL CHX at 48 hpi. At the
indicated times (hours) following CHX addition, total protein
was isolated, fractionated by SDS-PAGE, and analyzed by
immunoblotting using the indicated primary antibodies and
a secondary antibody covalently linked to an infrared fluorophore. The membrane was scanned, and the fraction of Paip2
remaining at each time point was quantified using an Odyssey
infrared imager. Each band was measured for raw intensity value,
and each time point was normalized to the amount of Paip2
present at time 0. (C) Paip2 was immunodepleted from soluble
cell-free extracts prepared from asynchronous NHDFs that were
either mock-infected (Mock) or HCMV-infected (wild type vs.
DUL38) at 48 hpi (MOI = 3). Samples of the input extracts and
the fractions not bound to anti-Paip2 antibody (flow-through)
were fractionated by SDS-PAGE and analyzed by immunoblotting using the indicated antisera.
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ability to bind PABP1 (Yoshida et al. 2006), variation in
Paip2 stability likely reflects changes in the balance of
free PABP1 to free Paip2. In this case, increasing PABP1
concentration in HCMV-infected cells would serve as
a sink to stabilize the pool of newly synthesized Paip2.
A key prediction of this model is that the virus-induced
increase in PABP1 concentration is sufficient to maintain
a pool of free PABP not bound to Paip2. To test this
hypothesis, the amounts of free PABP not bound to Paip2
in cell-free lysates prepared from NHDFs infected with
wild-type HCMV or a UL38-deficient virus (DUL38) that
is unable to increase PABP abundance were compared.
Initial levels of PABP1, Paip2, and UL38 were first evaluated in input lysates prepared from mock-infected versus
HCMV-infected (wild type vs. DUL38) by immunoblotting. As expected, PABP1 and Paip2 abundance both
increased in a UL38-dependent manner (Fig. 4C). However, following immunodepletion of Paip2 from cell-free
lysates, more PABP remained in the unbound fraction isolated from wild-type HCMV-infected cells compared with
cells infected with DUL38 or uninfected cells (Fig. 4C).
Thus, the HCMV-induced PABP1 increase is sufficient to
increase the concentration of free PABP1 not bound to its
inhibitor, Paip2, in a UL38-dependent manner.
Paip2 accumulation is triggered by the HCMV-induced
PABP1 increase and regulates eIF4F assembly
in infected cells
Having shown previously that the virus-induced PABP1
increase promoted virus replication, it was puzzling to
observe a concomitant rise in the level and stability of its
cognate repressor, Paip2, along with its negative regulator, EDD1. Thus, we next considered the hypothesis that
HCMV protein accumulation and replication were in fact
controlled by the dynamic interplay between PABP1 and
Paip2 levels. By reducing the abundance of the E3 ubiquitin ligase EDD1, binding of Paip2 to PABP1 increases,
stabilizing Paip2 and inhibiting PABP1 function (Yoshida
et al. 2006). Indeed, Paip2 abundance, but not PABP1 abundance, increased upon EDD1 depletion in HCMV-infected
cells. (Fig. 5A). Moreover, Paip2 accrual induced by EDD1
depletion coincided with a reduction in overall levels of
representative viral proteins (UL44 and ICP8) and suggests
that further increasing Paip2 concentration in HCMVinfected cells limits viral protein accumulation (Fig. 5A).
Preventing the virus-induced PABP1 increase using RNAi
in HCMV-infected cells markedly reduced accumulation
of viral gene products representing different temporally
expressed classes of viral genes (Fig. 5B, cf. lane 1 vs. 2) in
agreement with our earlier work (McKinney et al. 2012).
Moreover, we now demonstrate that it also resulted in
a corresponding reduction in Paip2 levels. Notably, no
differences in PABP1 or viral protein accumulation were
detected when Paip2 was depleted with siRNA (Fig. 5B,
cf. lane 1 vs. 3). This raised the possibility that PABP1 is
produced in vast excess in order to saturate the inhibitory
effects of Paip2.
To test the hypothesis that raising PABP1 abundance in
HCMV-infected cells is required to counteract the inhib-
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itory impact of Paip2, the remaining pool of Paip2 was
depleted in cells where the HCMV-induced PABP increase
was blocked using RNAi. Remarkably, Paip2 depletion in
HCMV-infected cells that were unable to increase PABP1
effectively restored viral protein production to levels
observed in cultures treated with control, nonsilencing
siRNA, or Paip2 siRNA alone (Fig. 5B, cf. lanes 4 and 3 or
1). Thus, similar levels of viral protein accumulation can
be achieved by depleting Paip2, effectively obviating the
need to increase intracellular PABP concentration. This
suggests that rising Paip2 levels function to restrict viral
replication, and this is effectively counteracted by raising
PABP1 concentration. It further implies that the increase
in Paip2 abundance occurs in response to rising PABP
levels.
To understand the underlying mechanism whereby Paip2
depletion allows HCMV protein accumulation to proceed
without raising intracellular PABP1 levels, the varied ways
by which PABP1 post-transcriptionally controls gene expression were examined. PABP1 regulates mRNA stability
by protecting mRNAs from deadenylation-mediated decay, and this could account for the observed changes in
viral protein accumulation (for review, see Mangus et al.
2003). However, the steady-state abundance of HCMV
pp28 and IE2 mRNAs did not detectably change when
infected cells were treated with siRNAs targeting PABP,
Paip2, or both PABP and Paip2 (Fig. 5C). PABP is also a
translation initiation factor (Kahvejian et al. 2005). While
HCMV infection, unlike many viruses, does not normally
impair ongoing cellular protein synthesis, altering the balance between PABP and Paip2 may impact the efficiency
with which viral versus host mRNAs access the translation
initiation machinery. Although preventing the HCMVinduced PABP increase modestly reduced global infected
cell protein synthesis, the overall profile of protein synthesis in infected cells was not grossly altered by Paip2
depletion in the presence or absence of PABP siRNA
treatment (Supplemental Fig. S2). Thus, translation of
viral mRNAs was not detectably enriched at the expense
of cellular mRNAs.
Besides stimulating protein accumulation, the HCMVinduced PABP increase effectively stimulated assembly of
eIF4E, eIF4G, and eIF4A into the heterotrimeric eIF4F
translation initiation factor complex (Kudchodkar et al.
2004; Walsh et al. 2005; McKinney et al. 2012). To evaluate
the impact of perturbing PABP/Paip2 homeostasis on
eIF4F assembly, cell-free lysates prepared from NHDFs
treated with siRNAs and subsequently mock-infected or
infected with HCMV were subjected to batch chromatography using m7GTP Sepharose. After washing the resin to
remove unbound and nonspecifically bound components,
bound proteins were fractionated by SDS-PAGE and analyzed by immunoblotting to evaluate binding of eIF4G
and eIF4A to the cap-binding protein eIF4E (Fig. 5D). While
preventing the HCMV-induced PABP1 increase using
RNAi substantially reduced the association of eIF4G
and eIF4A with eIF4E bound to the m7GTP cap affinity
resin (Fig. 5D, cf. lanes 2 and 3), Paip2 depletion modestly
increased eIF4G binding to eIF4E compared with lysates
prepared from cultures treated with control, nontargeting
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Figure 5. Increased Paip2 abundance in response to virus-induced PABP accumulation regulates eIF4F assembly and HCMV protein
production. (A) NHDFs transfected with the indicated siRNA (control nonsilencing siRNA [ctrl] or EDD1) were infected with HCMV at
MOI = 0.1. After 5 d, total protein was collected, fractionated by SDS-PAGE, and analyzed by immunoblotting with the indicated
antisera. (*) A nonspecific, cross-reacting band. (B) NHDFs transfected with a control nonsilencing siRNA (ctrl) or the indicated pairs of
siRNAs were infected with HCMV at MOI = 0.1. After 5 d, total protein was collected and analyzed as in A. (C) As in B, except that total
RNA was isolated using Trizol and subjected to RT-qPCR using primers specific for the HCMV IE2 or pp28 genes. Each reaction product
was normalized to the signal obtained using primers specific for 18S rRNA and expressed as the fold change relative to HCMV-infected
cells treated with control nonsilencing siRNA. (D) As in B, except that siRNA-treated NHDFs were mock-infected or HCMV-infected
(MOI = 3). After 5 d, cell-free extracts prepared using a nonionic detergent were subject to batch chromatography on m7GTP Sepharose.
A sample of input extract or m7GTP-bound proteins was fractionated by SDS-PAGE and analyzed by immunoblotting with the indicated
antisera.

siRNA (Fig. 5D, lane 2 vs. 4). Remarkably, Paip2-depletion
restored eIF4G and eIF4A binding to eIF4E in cells where
the HCMV-induced PABP increase was inhibited by PABP
siRNA. This was specific for HCMV-infected cells and not
observed in uninfected cells (Supplemental Fig. S3). Thus,
the defect in translation initiation factor eIF4F assembly

resulting from failure to increase PABP1 concentration in
HCMV-infected cells can be effectively corrected by Paip2
depletion. Furthermore, it implies that existing supplies of
Paip2 effectively restrict eIF4F assembly, and this can be
counteracted by a commensurate virus-induced rise in
PABP1 concentration.

GENES & DEVELOPMENT

1815

Downloaded from genesdev.cshlp.org on October 1, 2015 - Published by Cold Spring Harbor Laboratory Press

McKinney et al.

Paip2 is a host antiviral restriction factor antagonized
by PABP accumulation in HCMV-infected cells
To determine whether Paip2 acts as a restriction factor
that limits viral productive growth and spread in cells
where the HCMV-induced PABP increase is blocked,
NHDFs treated with siRNA (control, PABP1, Paip2, or
both PABP and Paip2) were infected with HCMV, and viral
replication was evaluated. Under these conditions (multiplicity of infection [MOI] = 0.1), preventing the virusinduced PABP increase using PABP1 siRNA reduced viral
replication, whereas Paip2 depletion had a very slight but
not significant impact. Significantly, depleting Paip2 in cells
where the HCMV-induced PABP increase was blocked
resulted in a 40-fold increase of viral replication, restoring
viral growth in NHDFs to levels observed in cultures
treated with control, nonsilencing siRNA or Paip2 siRNA
alone (Fig. 6A,B). Thus, the HCMV-induced increase in
PABP1 levels controls viral growth by antagonizing the
corresponding increase in the host Paip2 inhibitor. This
establishes that the cellular Paip2 can function as a host
restriction factor to antagonize viral replication. Furthermore, it provides the first example of a virus that
manipulates the PABP/Paip2 axis to specifically counteract Paip2 and foster viral protein accumulation and
replication.
Discussion
To ensure that viral mRNAs effectively compete with
cellular mRNAs for limiting translation factors, HCMV
uses an unusual strategy and forces its host to increase
the overall abundance of several critical initiation factors,
one of which is PABP1 (Isler et al. 2005; Walsh et al. 2005).
The resulting accumulation of PABP1 in HCMV-infected
cells is required to stimulate eIF4F assembly, viral protein
production, and replication (McKinney et al. 2012). Here,
we show that the PABP1 repressor Paip2 and EDD1, a
ubiquitin E3 ligase that regulates Paip2 stability, unexpectedly increase together with PABP upon infection.
The coordinate regulation of PABP1, Paip2, and EDD1 is
dependent on the HCMV mTORC1 activator encoded by
the UL38 gene. Preventing the HCMV-induced increase
in PABP1 abundance not only impaired viral protein production and replication, but also inhibited the rise in
Paip2 levels. Surprisingly, depleting Paip2 in cells where
the HCMV-induced PABP increase was blocked restored
their ability to support viral protein production and replication without a commensurate increase in PABP1
levels. This establishes a role for the host PABP inhibitor
Paip2 in infection biology, where it can function as an
innate defense that restricts viral protein synthesis and
replication. Moreover, it provides the first example of
how a pathogen can manipulate the cellular PABP1–Paip2
homeostatic axis by raising PABP1 levels to overwhelm
the functional capacity of its inhibitor, Paip2.
While previous studies showed that depleting PABP1
coordinately reduced Paip2 stability in a manner requiring the ubiquitin E3 ligase EDD1 (Yoshida et al. 2006), the
effect of increasing PABP1 concentration on Paip2 levels
was never addressed, in part due to difficulties associated
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Figure 6. Endogenous Paip2 functions to restrict productive
HCMV growth when the virus-induced PABP accumulation is
blocked. (A) NHDFs transfected with a control nonsilencing
siRNA (ctrl) or the indicated pairs of siRNAs were infected with
HCMV (MOI = 0.1) and imaged for EGFP expression 5 d postinfection. (B) Supernatants collected from three independent
experiments detailed in A were assayed for viral particle
production based on their TCID50 (Heider et al. 2002). Error
bars indicate standard error of the mean. (*) P < 0.022 for control
versus PABP1 siRNA; (**) P < 0.01 for PABP1 versus PABP1/Paip2
siRNA. Control versus Paip2 was not statistically significant
(P > 0.1).

with overexpressing PABP (Wormington et al. 1996; Wu
and Bag 1998; Hornstein et al. 1999b; Ma et al. 2006).
Indeed, the biological benefit of destabilizing Paip2 when
PABP1 levels fall intuitively preserves a pool of functional
PABP1, which would otherwise be inhibited by Paip2
under these circumstances (Yoshida et al. 2006). The rise
in Paip2 and EDD1 that accompanies the PABP1 increase,
however, is more perplexing at first glance, as it has the
potential to neutralize the investment involved in making
more PABP1. Perhaps the coordinate increase in activator
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and inhibitor allows for a ready-made supply of inhibitor
that can be rapidly enlisted to upset the delicate PABP1–
Paip2 balance and thereby antagonize the newly set,
elevated PABP1 levels. As PABP1 binds to mRNA in both
noncooperative and cooperative modes, the latter involving homophillic protein–protein interactions that promote PABP multimerization on the mRNA poly(A) tail
(Kühn and Pieler 1996; Melo et al. 2003; Lin et al. 2012),
relatively small changes in the free PABP pool could have
a significant impact on binding of the initial subunits to
poly(A) mRNA termini. Thus, besides expanding the available pool of free PABP not bound to Paip2, the virusinduced PABP1 increase likely ensures that the intracellular PABP concentration is sufficient for PABP binding to
and subsequent multimerization on mRNA. Alternatively,
there may also be ways to increase PABP1 without
elevating Paip2 or EDD1, and the corresponding rise in
Paip2 could be viewed as a host response to infection or
stress. In support of this hypothesis, preventing the HCMVinduced PABP increase also suppressed Paip2 accumulation,
suggesting that increasing Paip2 abundance is a host
response to elevated PABP concentration.
While cellular translation repressors that regulate eIF4F
assembly from its component subunits (eIF4E, eIF4G, and
eIF4A) are inactivated in herpesvirus-infected cells (Walsh
and Mohr 2011), this is the first demonstration of a role
for the PABP1–Paip2 axis. Assembly of eIF4F is controlled
in part by the availability of its eIF4E subunit, which is
regulated by the abundance and phosphorylation status
of its repressor protein, 4E-BP1 (Gingras et al. 1999). Remarkably, the levels of the repressors 4E-BP1 and Paip2
are controlled by a homeostatic mechanism that responds
to the abundance of their respective cognate initiation
factors, eIF4E and PABP1 (Yoshida et al. 2006; Yanagiya
et al. 2010). Furthermore, both repressors appear to be
regulated by mTORC1 signaling, which is constitutively
activated in HCMV-infected cells by the TSC2-binding
protein UL38. Notably, antagonizing translation repressors like 4E-BP1 and now Paip2 by virus-encoded factors
in infected cells is consistent with the notion that host
translation control pathways function as innate defenses
with the capacity to restrict productive viral replication.
Indeed, the observation that Paip2 depletion restores viral
replication in infected cultures where the virus-induced
PABP1 increase is blocked implies that Paip2 restricts
viral replication by limiting PABP1 availability. Furthermore, restoration of replication to levels that exceed wild
type by depleting Paip2 in cells where the HCMV-induced
PABP increase was blocked suggests that the scope of
PABP1 function can be maintained with far less PABP1
than is induced by HCMV. It also implies that translationally up-regulating PABP1 is meant to overcome the antiviral response of increasing Paip2. Additional virus-encoded
functions, including the UL69 RNA-binding protein that
associates with PABP and eIF4A (Aoyagi et al. 2010), may
also help preserve PABP function by limiting its availability to interact with Paip2.
Although Paip2 clearly is an important inhibitor of
PABP1 function, spermatogenesis in mice, growth control in Drosophila, synaptic plasticity, and memory in

mice are the only biological process with a documented
role for Paip2 (Roy et al. 2002; Yanagiya et al. 2010;
Khoutorsky et al. 2013). Our study establishes that Paip2
can play a significant role in infection biology by altering
the balance of PABP1 with its cognate repressor. Importantly, infection is a potent stress, and translational control is a major means whereby stress-induced gene
expression is controlled. This raises the possibility that
Paip2 might play a more global role in controlling PABP1
levels in response to stress in uninfected cells. Future
studies in other model systems are required to address
this possibility and uncover any parallels with changes to
Paip2, EDD1, and PABP1 in HCMV-infected cells.
Even though Paip2 protein synthesis increases in an
mTORC1-dependent manner, Paip2 mRNA does not contain a TOP sequence element. While TOP mRNA translation is stimulated in HCMV-infected cells (McKinney
et al. 2012), Paip2 represents the first host mRNA whose
translation is specifically controlled in infected cells
and is not a TOP family member. Thus, while mTORC1
activation controls translation of canonical TOP mRNAs
in HCMV-infected cells, non-TOP-containing mRNAs
like Paip2 are poised to respond to other translational
regulators, like PABP. By not suppressing host mRNA
translation, HCMV provides a unique model to evaluate
how differential host mRNA translation might impact
infection. Translationally regulated host factors might be
required, like PABP1, to stimulate viral replication or
contribute to host defenses and thereby restrict viral
replication like Paip2. Although the extent to which
host mRNAs are translationally controlled in HCMVinfected cells and their contribution to virus biology
remain to be elucidated, they could reveal a powerful
means to control viral replication and allow viruses to
access a wealth of functions encoded by host genomes.
Likewise, it may also provide infected hosts with a valuable opportunity to attempt to restrict viral replication
and identify new innate defense effectors whose synthesis is transitionally regulated. Finally, the HCMV model
system may provide valuable insight into how different
mRNA populations are either recruited or excluded from
polyribosomes.
Materials and methods
Cell culture and viruses
NHDFs (purchased from Clonetics) were routinely subcultured by
a 1:3 split and maintained until passage 20 in DMEM supplemented with 5% FBS, 1% L-glutamine, and 1% penicillin/
streptomycin (v/v). GFP-expressing HCMV (AD169 strain) wildtype, UL38-null (DUL38), or UL38 revertant (REV) viruses were
propagated as described (Terhune et al. 2007). Akt inhibitor VIII
was purchased from Sigma.

Quantitative PCR (qPCR), antibodies, and Western blotting
RNA was isolated from cell-free lysates and processed into cDNA
for qPCR as described (McKinney et al. 2012). The following
primers were used for qPCR analysis: PABP1 (fw, CCCAGCTG
CTCCTAGACC; and rev, GAGTAGCTGCAGCGGCT), Paip2
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(purchased from Origene), EDD1 (UBR5; purchased from Origene),
18s (fw, AGGAATTGACGGAAGGGCACCA; and rev, TTATC
GGAATTAACCAGACAAATCG), pp28 (fw, TGCTCTGGGT
CGCCAGGTGT; and rev, CAGCCACTACCGCAGAGCC), and
IE2 (fw, CGGGTGGATGTGTCACGGGC; and rev, ACGCACC
CGCTCTCCCAGA).
Protein lysates were collected and subjected to SDS-PAGE and
Western blotting as described (Walsh and Mohr 2004). AntiPABP1 rabbit polyclonal was a gift from Simon Morley (University Sussex, UK), and anti-UL38 mouse monoclonal was a gift
from Tom Shenk (Princeton University). The following primary
antibodies were purchased commercially: anti-Paip2 (Sigma, no.
P0087), anti-actin (Calbiochem, no. CP01), anti-EDD1 (Bethyl
Laboratories, no. A300-573A-2), anti-Akt (Cell Signaling, no.
9272); anti-pp28 (Abcam, no. ab6502), anti-IE1/2 (Millipore, no.
MAB810), and anti-UL44 (Virusys, no. CA006). For quantitative
immunoblotting, a secondary antibody covalently linked to an
infrared fluorophore was used (Li-Cor Biosciences, no. 827-08365)
and the membrane was scanned using an Odyssey infrared imager
(Li-Cor Biosciences).
Protein half-life analysis, immunoprecipitation, and Paip2
immunodepletion.
Mock-infected or HCMV-infected cells were treated with
100 mg/mL CHX (Research Products International Corp.) for up
to 9 h. Western blots were quantified (n = 3) using an Odyssey
infrared imager (Li-Cor Biosciences). To determine the efficacy of
CHX treatment, cells were pulse-labeled with 35S-labeled amino
acids at the indicated times, and the amount of acid-insoluble
radioactivity present in cell-free lysates was quantified as described (McKinney et al. 2012).
Paip2 was immunoprecipitated from cell-free lysates prepared
from mock-infected or HCMV-infected NHDFs (1.3 3 106 cells
per sample) harvested at 48 hpi. After washing with cold PBS,
cells were suspended in NP40 lysis buffer (50 mM HEPES at pH
7.4, 100 mM NaCl, 1.5 mM MgCl2, 2 mM EDTA, 0.25% NP40,
13 Roche Phos Stop, protease inhibitor tablets). Lysates were
gently rocked for 30 min at 4°C, and, subsequently, lysates were
clarified by centrifugation (12,000g) for 10 min at 4°C. CaCl2 (1 mM
final concentration) was added to soluble supernatants (0.5 mL),
which were subsequently treated with a nuclease cocktail (4 U of
micrococcal nuclease [New England Biolabs, no. M0247S], 150 U
of RNase T1, 3.75 U of RNase A [Ambion, no. AM2286]) for
20 min at room temperature. Nuclease-treated lysates were precleared by adding 5 mg of purified normal rabbit serum (Invitrogen,
no. 17-0780-01) for 1 h at 4°C, and nonspecific binding proteins
were subsequently collected by incubation with 10 mL of packed
bed volume of protein A Sepharose CL-4B (GE Healthcare, no. 17780-01) for 1 h at 4°C. An aliquot of soluble, precleared extract
(10%) was removed (input fraction), diluted 1:2 in SDS sample
buffer, and reserved for later analysis. Anti-Paip2 antibody (5 mg)
was added to the remainder of the precleared lysate, and the
mixture used to resuspend 10 mL of packed bed volume of
protein A Sepharose. After overnight incubation at 4°C, the
beads and supernatant were partitioned by brief centrifugation
in a microfuge, and the soluble flow-through fraction was
removed for analysis by immunoblotting (together with the
input fraction). For analysis of Paip2 and Paip-2-associated
proteins, the beads were next washed three times (0.5 mL per
wash) with NP40 lysis buffer, suspended in SDS-containing
sample buffer, and boiled for 3 min. Immune complexes were
fractionated by SDS-PAGE and analyzed by immunoblotting.
For analysis of PABP and PABP-associated proteins, a similar
immunoprecipitation protocol was performed using anti-PABP
antibody.
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Generating UL38-expressing cells and

35

S metabolic labeling

To generate a dox-inducible, UL38-expressing cell line, the 990base-pair (bp) UL38 gene was PCR-amplified from a pRetro-EBNAUL38 vector (Moorman et al. 2008) with fw (GACAGGAACTAG
TATACCACGCATAGCACT) and rev (ATACGGCCTCGAGCT
GACCACCATCTGTAC) primers bearing SpeI and XhoI overhangs, respectively. The product was then digested, purified, and
cloned into a pSLIK tet-inducible vector as described (Kobayashi
et al. 2012).
Lentiviruses were produced as described (Kobayashi et al. 2012),
and a population of transduced cells was selected using 50 mg/mL
hygromycin B (Life Technologies).

RNAi, microscopy, and viral replication assay
PABP1, Paip2, and EDD1 siRNA smartpools were purchased from
Dharmacon (catalog nos. M019598, M015376, and M007189,
respectively). Transfections of siRNAs, low MOI HCMV infections, and viral replication assays were conducted as described
(McKinney et al. 2012). For depleting EDD1, 20 nM siRNA was
transfected. For depleting two target genes, 20 nM siRNA was
transfected for each target (40 nM siRNA total siRNA). EGFP
expression was used to measure HCMV spread and was visualized under 53 magnification using a Zeiss Axiovert 200 fluorescent microscope. A paired two-tailed t-test was used to calculate
P-values.
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